US network health desk; pre-launch explainer published June 29 covering coverage mechanics and patient eligibility

CNN framed the July 1 launch as the first time in Medicare's 60-year history that the program has covered weight-loss drugs. The piece explained that CMS's GLP-1 Bridge demonstration runs through December 2027 and that qualifying patients must have a body mass index at or above 35 or a lower BMI with at least one cardiovascular or metabolic comorbidity. The administration struck the $50 price deal directly with Eli Lilly and Novo Nordisk in November 2025 as part of broader drug-pricing negotiations.

“Medicare will start covering weight-loss drugs on July 1 for the first time.”